Skip to main content
Back
Watch Compare

Caribou Biosciences, Inc.

Data quality: 100%
CRBU
Nasdaq Manufacturing Chemicals
$1.97
▲ $0.02 (1.03%)
Mkt Cap: 190.38 M
Price
$1.97
Mkt Cap
190.38 M
Day Range
$1.93 — $2.00
52-Week Range
$0.71 — $3.54
Volume
724,676
Open $1.95
50D / 200D Avg
$1.76
11.63% above
50D / 200D Avg
$1.88
4.69% above

Quick Summary

Key Takeaways

Revenue grew 3.84% annually over 5 years — modest growth
Negative free cash flow of -112.35 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.82%

Growth

Revenue Growth (5Y)
3.84%
Above sector avg (1.82%)
Revenue (1Y)11.66%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-96.19%
Below sector avg (-53.41%)
ROIC-65.30%
Net Margin-1327.40%
Op. Margin-1329.37%

Safety

Debt / Equity
N/A
Current Ratio5.54
Interest CoverageN/A

Valuation

PE (TTM)
-1.29
Above sector avg (-1.48)
P/B Ratio1.34
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.3 -1.5
P/B 1.3 1.6
ROE % -96.2 -53.4
Net Margin % -1327.4 -41.5
Rev Growth 5Y % 3.8 1.8
D/E — 0.3

ETFs Holding This Stock

NXTE logo NXTE AXS Green Alpha ETF
0.79% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 11.66% Revenue Growth (3Y) -43.11%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 3.84% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 11.16 M Net Income (TTM) -148.13 M
ROE -96.19% ROA -71.23%
Gross Margin N/A Operating Margin -1329.37%
Net Margin -1327.40% Free Cash Flow (TTM) -112.35 M
ROIC -65.30% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.54
Interest Coverage N/A Asset Turnover 0.05
Working Capital 127.45 M Tangible Book Value 141.85 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.29 Forward P/E N/A
P/B Ratio 1.34 P/S Ratio 17.06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -59.02%
Market Cap 190.38 M Enterprise Value 179.23 M
Per Share
EPS (Diluted TTM) -1.59 Revenue / Share 0.12
FCF / Share -1.16 OCF / Share -1.15
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 12.18% FCF Conversion 75.85%
SBC-Adj. FCF -126.36 M Growth Momentum 7.82

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 11.16 M 9.99 M 34.48 M 13.85 M 9.60 M
Net Income -148.13 M -149.11 M -102.07 M -99.42 M -66.92 M
EPS (Diluted) -1.59 -1.65 -1.38 -1.64 —
Gross Profit — — — — —
Operating Income -148.34 M -166.62 M -116.06 M -106.40 M -66.98 M
EBITDA — — — — —
R&D Expenses 109.44 M 130.15 M 112.08 M 82.23 M 52.26 M
SG&A Expenses — — — — —
D&A 3.65 M 3.93 M 3.53 M 1.62 M 984,000.0
Interest Expense — — — — 8,000.0
Income Tax -550,000.0 -9,000.0 193,000.0 70,000.0 321,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 175.37 M 313.31 M 432.21 M 373.77 M 442.36 M
Total Liabilities 53.19 M 60.36 M 63.81 M 72.89 M 54.53 M
Shareholders' Equity 122.18 M 252.95 M 368.40 M 300.87 M 387.83 M
Total Debt — — — — —
Cash & Equivalents 12.36 M 16.29 M 51.16 M 58.34 M 240.42 M
Current Assets 145.23 M 219.38 M 338.84 M 260.25 M 391.19 M
Current Liabilities 25.41 M 30.65 M 28.30 M 28.13 M 25.83 M